Ledger.Open graph →
SEC Form D · filed February 17, 2015

Miragen Therapeutics Inc

Offering
$20.0M
Sold
$8.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boulder, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

William S. Marshall · Boulder, COExec · DirectorKyle H. Lefkoff · Boulder, CODirectorJason A. Leverone · Boulder, COExecJohn W. Creecy · Boulder, CODirectorThomas E. Hughes · Boulder, CODirectorBruce L. Booth · Boulder, COExec · DirectorMarvin S. Caruthers · Boulder, CODirectorChristopher J. Morl · Boulder, COExecDavid J. Rodman · Boulder, COExecBryan E. Thurston · PORTLAND, ORDirectorJames E. Dickinson · PORTLAND, ORDirectorAnish J. Parvatanini · CHICAGO, ILDirectorArjuna J. Ariathurai · CHICAGO, ILExec · DirectorChun E. Liu · PORTLAND, ORExec · DirectorAnthony B. Lennen · Indianapolis, INExec · DirectorKurt H. Martin · Indianapolis, INExecGlen A. Brunk · Indianapolis, INExec · DirectorAmy D. Glover · Indianapolis, INExec · DirectorAndrew D. Corsaro · Indianapolis, INExecS. C. Lottich · Indianapolis, INDirectorPhilip B. Palmer · SAVANNAH, GAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗